209 related articles for article (PubMed ID: 20691029)
1. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma.
Wiley JL; Rook KA; Clifford CA; Gregor TP; Sorenmo KU
Vet Comp Oncol; 2010 Sep; 8(3):221-33. PubMed ID: 20691029
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
[TBL] [Abstract][Full Text] [Related]
4. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
Finotello R; Stefanello D; Zini E; Marconato L
Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.
Teske E; Rutteman GR; Kirpenstein J; Hirschberger J
Vet Comp Oncol; 2011 Dec; 9(4):283-9. PubMed ID: 22077409
[TBL] [Abstract][Full Text] [Related]
6. Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
Borgatti A; Fieberg A; Winter AL; Stuebner K; Taras E; Todhunter D; Masyr A; Rendhal A; Vallera DA; Koopmeiners JS; Modiano JF
Vet Comp Oncol; 2020 Dec; 18(4):664-674. PubMed ID: 32187827
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin chemotherapy for presumptive cardiac hemangiosarcoma in dogs
Mullin CM; Arkans MA; Sammarco CD; Vail DM; Britton BM; Vickery KR; Risbon RE; Lachowicz J; Burgess KE; Manley CA; Clifford CA
Vet Comp Oncol; 2016 Dec; 14(4):e171-e183. PubMed ID: 25524594
[TBL] [Abstract][Full Text] [Related]
8. Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases.
Martano M; Morello E; Ughetto M; Iussich S; Petterino C; Cascio P; Buracco P
Vet J; 2005 Jul; 170(1):84-90. PubMed ID: 15993791
[TBL] [Abstract][Full Text] [Related]
9. Surgery and doxorubicin in dogs with hemangiosarcoma.
Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
[TBL] [Abstract][Full Text] [Related]
10. Treatment with DAV for advanced-stage hemangiosarcoma in dogs.
Dervisis NG; Dominguez PA; Newman RG; Cadile CD; Kitchell BE
J Am Anim Hosp Assoc; 2011; 47(3):170-8. PubMed ID: 21498593
[TBL] [Abstract][Full Text] [Related]
11. Outcome of dogs with high-grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996-2004).
Selting KA; Powers BE; Thompson LJ; Mittleman E; Tyler JW; Lafferty MH; Withrow SJ
J Am Vet Med Assoc; 2005 Nov; 227(9):1442-8. PubMed ID: 16279389
[TBL] [Abstract][Full Text] [Related]
12. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
Burton JH; Powers BE; Biller BJ
Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989-1999).
Hahn KA; Endicott MM; King GK; Harris-King FD
J Am Vet Med Assoc; 2007 Sep; 231(5):742-5. PubMed ID: 17764436
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA
Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259
[TBL] [Abstract][Full Text] [Related]
17. Primary rib tumors in 54 dogs.
Pirkey-Ehrhart N; Withrow SJ; Straw RC; Ehrhart EJ; Page RL; Hottinger HL; Hahn KA; Morrison WB; Albrecht MR; Hedlund CS
J Am Anim Hosp Assoc; 1995; 31(1):65-9. PubMed ID: 7820767
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.
Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F
J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*.
Szivek A; Burns RE; Gericota B; Affolter VK; Kent MS; Rodriguez CO; Skorupski KA
Vet Comp Oncol; 2012 Mar; 10(1):65-73. PubMed ID: 22236371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
